Virginia Tech® home

Archived Seminar: Unlocking the Neurodevelopmental Effects of Cannabis and Relevance to Psychiatric Risk

Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC

Archived Seminar: Unlocking the Neurodevelopmental Effects of Cannabis and Relevance to Psychiatric Risk

Date: Oct. 23, 2020
Time: 11:00 a.m. - 12:00 p.m.

Loading player for https://youtu.be/tGOYihtFudo...

Abstract

The sociopolitical landscape has dramatically changed regarding the medical and recreational  use of cannabis. This talk will provide insights about advances made about the molecular underpinnings of developmental cannabis/THC exposure that maintains a long-term impact on adult behavior. The research describes translational and multidisciplinary scientific approaches ranging from molecular and epigenetic studies in animal models to investigations in human subjects.

Additional Details 

This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Center for Human Neuroscience Research. The Fralin Biomedical Research Institute Pioneers in Biomedical Research Program offers the expertise of a range of scientists who are exploring frontiers in biomedical research. These seminars are open to Virginia Tech and Carilion Clinic faculty, students, and staff.

 

You May Also Be Interested In...

  • Home Item
    Sudden Cardiac Arrest in the Young: The Case of ARVC , home

    Oct. 18, 2024, 11:00 a.m. | Mario Delmar, M.D., Ph.D., Endowed Professor of Medicine, Patricia and Robert Martinsen Professor of Cardiology, Leon H Charney Division of Cardiology, New York University School of Medicine | Pioneers in Biomedical Research Seminar, Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research

  • Home Item
    Harnessing Interoception: Innovative Approaches for Psychiatric Assessment and Intervention , home

    Oct. 25, 2024, 11:00 a.m. | Sahib Khalsa, M.D., Ph.D., Associate Professor, Louis Jolyon West Innovation Chair, Director of Anxiety Disorders Research, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles| Co-Sponsored by the Center for Health Behaviors Research and the Addiction Recovery Research Center, Fralin Biomedical Research Institute

  • Home Item
    Clinical Applications of Cancer Genetics , home

    Nov. 21, 2024, 5:30 p.m. (Reception at 5 p.m.) | Luis Diaz, Jr., M.D., Head, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center; Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture

  • Home Item
    A Ribocentric View of Muscle Proteostasis in Health and Disease: Novel Mechanisms Potential Therapeutic Opportunities , home

    Nov. 22, 2024, 11:00 a.m. | Gustavo A. Nader, Ph.D., FAPS, Professor, College of Health and Human Development; Chair, Molecular, Cellular, and Integrative Physiology; Huck Institutes of the Life Sciences; The Pennsylvania State University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research

  • Home Item
    Human Laboratory Evaluation of Cannabis Products , home

    Dec. 13, 2024, 11:00 a.m. | Ryan Vandrey, Ph.D., Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and the Addiction Recovery Research Center

Yasmin Hurd, Ph.D. to present at Fralin Biomedical Research Institute

Yasmin Hurd, Ph.D.

Professor in the Department of Psychiatry, Neuroscience, and Pharmacology, and the Department of Systems Therapeutics, at the Icahn School of Medicine; and Director of the Addiction Institute at Mount Sinai